Brefeldin A inhibits vesicular MHC class I processing in resting but not in CpG- and disruption-activated DC

Molecular Immunology
Liying Chen, M Jondal

Abstract

Dendritic cells (DC) can process exogenous proteins for presentation on MHC class I (MHC-I) in a vesicular pathway (VP) that is distinct from the classical, cytosolic MHC-I pathway. Here we investigate the sensitivity of this VP to Brefeldin A (BFA), a fungal metabolite which inhibits vesicular trafficking by preventing the activation of some ADP-ribosylation factor (ARF) proteins, in both resting and differently activated DC. The VP could be directly visualized in DC by the presence of OVA-derived H-2K(b)/SIINFEKL complexes in a LAMP1 positive, but EEA negative, compartment in wt but not in cathepsin S(-/-) mice as these are unable to process OVA into the SIINFEKL peptide in endolysosomes. BFA, which binds to specific ARF-GDP-sec7 sites, both in the Golgi and in endolysosomes, was found to bind to and inhibit the VP in resting DC. If the VP was selectively activated with an immunostimulatory CpG ODN, binding to endolysosomal TLR9 receptors, or by the mere mechanical disruption of clustered DC cells, BFA no longer had this effect. The activation of the VP with both CpG and cellular disruption was found to be dependent on the MyD88 adaptor protein. We conclude that vesicular MHC-I processing in DC occurs in ARF-regulated LAMP1 p...Continue Reading

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J KarttunenN Shastri
Jan 1, 1989·Cold Spring Harbor Symposia on Quantitative Biology·C A Janeway
Sep 1, 1995·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Y DengJ W Yewdell
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Jan 14, 1994·Cell·K A HogquistF R Carbone
Jan 1, 1996·Critical Reviews in Immunology·C V Harding
Aug 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·S RobineauB Antonny
Mar 1, 2003·Science·E Sergio TrombettaIra Mellman
May 3, 2003·Annals of the New York Academy of Sciences·Ralph M SteinmanMichel Nussenzweig
Dec 4, 2003·Nature Reviews. Immunology·Jonathan W YewdellJacques Neefjes
Jan 31, 2004·Seminars in Immunology·Fumihiko TakeshitaDennis M Klinman
Mar 30, 2004·European Journal of Immunology·Liying Chen, Mikael Jondal
Jun 30, 2004·Nature Immunology·Anne L Ackerman, Peter Cresswell
Nov 20, 2004·Immunology and Cell Biology·Vanessa DurandAgnes Le Bon
Dec 21, 2004·Springer Seminars in Immunopathology·Kenneth L RockYan Shi
Mar 18, 2005·Annual Review of Immunology·E Sergio Trombetta, Ira Mellman
May 17, 2005·Journal of Leukocyte Biology·Annette M Marleau, Nora Sarvetnick
Nov 29, 2005·Trends in Immunology·David van DuinAlbert C Shaw
Jan 18, 2006·Cell Death and Differentiation·T Kawai, S Akira
Mar 22, 2006·Evidence-based Complementary and Alternative Medicine : ECAM·Tsukasa SeyaMisako Matsumoto
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Crislyn D'Souza-Schorey, Philippe Chavrier
May 13, 2006·Nature Reviews. Immunology·Caetano Reis e Sousa
Jul 14, 2007·European Journal of Immunology·Antje HeitHermann Wagner

❮ Previous
Next ❯

Citations

Jan 12, 2011·Immunology and Cell Biology·Stephanie J WinMargaret A Baird
Oct 31, 2009·Scandinavian Journal of Immunology·L Chen, M Jondal
Dec 24, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kenneth L RockLianjun Shen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.